TGFB1 and Myocardial fibrosis: In T1D rats, Calhex231 could inhibit the TGF-β1/Smads pathway and then depress the proliferation of cardiac fibroblasts, along with the reduction deposition of collagen, alleviating glucose-induced myocardial fibrosis [60].